Merck / MSD announces upcoming addition of Mary Ellen Coe to its Board of Directors

– USA, NJ –  Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Mary Ellen Coe, president, Google Customer Solutions, at Google Inc. will join the company’s Board of Directors effective March 18, 2019.

Ms. Coe will stand for election with the company’s other directors in connection with Merck’s Annual Meeting of Shareholders on May 28, 2019. With the addition of Ms. Coe, the Merck board will include 13 members.

“We are pleased to welcome such a highly respected business leader in technology as Ms. Coe to the Merck board and look forward to benefiting from her deep understanding of the evolving digital marketplace. As the health care system continues to evolve, Ms. Coe’s strategic perspective and operational expertise at one of the world’s most innovative companies will be a significant asset to Merck,” said Kenneth C. Frazier, chairman and chief executive officer, Merck.

About Mary Ellen Coe

Ms. Coe currently serves as president of Google Customer Solutions at Google where she oversees the global ads business for mid-market and small businesses, serving millions of customers and thousands of partners worldwide. Prior to joining Google in 2012, Ms. Coe was a principal at the global consulting firm McKinsey & Co. and a leader of the firm’s consumer marketing and sales practice in North America. Earlier in her career, Ms. Coe worked in product marketing, advertising and brand strategy. Ms. Coe is a member of the advisory board of the Ross Business School at the University of Michigan, and served on the board of Whole Foods Market, Inc., chairing the Nominations and Governance Committee. Ms. Coe earned her Bachelor of Arts from the University of Michigan-Ann Arbor.

About Merck

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.